Literature DB >> 20353461

Retransplantation after BK virus nephropathy in prior kidney transplant: an OPTN database analysis.

V R Dharnidharka1, W S Cherikh, R Neff, Y Cheng, K C Abbott.   

Abstract

BK virus (BKV) has emerged as a major complication of kidney transplantation. Since June 30, 2004, the OPTN in the USA collects BKV as a primary or secondary cause of graft loss and also if treatment for BK virus (TBKV) is administered. In this study, we determined characteristics of those recipients of repeat kidney transplants from the OPTN database, where either (a) a graft loss occurred between June 30, 2004 and December 31, 2008 and database recorded prior TBKV in that allograft or (b) a graft loss between June 30, 2004 and December 31, 2008 was attributed primarily or secondarily due to BKV. In the study time period, 823 graft losses have occurred where TBKV or graft failure attributable to BKV was reported in prior transplant; of these, 126 have received a retransplant as of June 5, 2009. Induction and maintenance immunosuppression usage mirrored current trends. As of June 5, 2009, 118/126 grafts are still functioning, one graft failure attributed to BKV. TBKV was reported in 17.5% of the retransplants. In the retransplants performed through December 31, 2007, 1-year acute rejection rate was 7%, 1-year and 3-year Kaplan-Meier graft survival rates and median GFR were 98.5%, 93.6%, 65.5 and 68.4 mL/min, respectively. Retransplantation after BKV appears to be associated with good results.

Entities:  

Mesh:

Year:  2010        PMID: 20353461     DOI: 10.1111/j.1600-6143.2010.03083.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  15 in total

1.  BK Virus Nephropathy.

Authors:  Deirdre Sawinski; Jennifer Trofe-Clark
Journal:  Clin J Am Soc Nephrol       Date:  2018-09-21       Impact factor: 8.237

2.  Adaptive immunity rather than viral cytopathology mediates polyomavirus-associated nephropathy in mice.

Authors:  J A Albrecht; Y Dong; J Wang; C Breeden; A B Farris; A E Lukacher; K A Newell
Journal:  Am J Transplant       Date:  2012-03-15       Impact factor: 8.086

Review 3.  [BK virus nephropathy after kidney transplantation].

Authors:  V Bröcker; A Schwarz; J U Becker
Journal:  Pathologe       Date:  2011-09       Impact factor: 1.011

Review 4.  Mechanisms of BK virus infection of renal cells and therapeutic implications.

Authors:  Christiane Mbianda; Ashraf El-Meanawy; Andrey Sorokin
Journal:  J Clin Virol       Date:  2015-08-06       Impact factor: 3.168

5.  The Banff 2009 Working Proposal for polyomavirus nephropathy: a critical evaluation of its utility as a determinant of clinical outcome.

Authors:  K Masutani; R Shapiro; A Basu; H Tan; M Wijkstrom; P Randhawa
Journal:  Am J Transplant       Date:  2012-03-05       Impact factor: 8.086

Review 6.  Management of polyomavirus-associated nephropathy in renal transplant recipients.

Authors:  Dirk R J Kuypers
Journal:  Nat Rev Nephrol       Date:  2012-04-17       Impact factor: 28.314

7.  Modest rates and wide variation in timely access to repeat kidney transplantation in the United States.

Authors:  Jesse D Schold; Joshua J Augustine; Anne M Huml; John O'Toole; John R Sedor; Emilio D Poggio
Journal:  Am J Transplant       Date:  2019-11-15       Impact factor: 8.086

Review 8.  Kidney retransplantation in children following rejection and recurrent disease.

Authors:  Rebecca C Graves; Richard N Fine
Journal:  Pediatr Nephrol       Date:  2016-04-05       Impact factor: 3.714

9.  Renal association clinical practice guideline in post-operative care in the kidney transplant recipient.

Authors:  Richard J Baker; Patrick B Mark; Rajan K Patel; Kate K Stevens; Nicholas Palmer
Journal:  BMC Nephrol       Date:  2017-06-02       Impact factor: 2.388

Review 10.  The BK virus in renal transplant recipients-review of pathogenesis, diagnosis, and treatment.

Authors:  Vikas R Dharnidharka; Husam A Abdulnour; Carlos E Araya
Journal:  Pediatr Nephrol       Date:  2010-12-15       Impact factor: 3.651

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.